Neuroscience & Mechanisms at 6th Annual Conference on Psychedelics and Psychedelic Medicine

6 sessions on neuroscience & mechanisms · November 13–14, 2026, Boston, MA. Compare neuroscience & mechanisms at other meetings →

Friday, November 13

  • 08:35–08:55 · Lecture · Module 1: Introduction and Keynote

    Psychedelic Pharmacology for Clinicians

    Franklin King

    Clinician-oriented overview of the pharmacology of psychedelic compounds.

    Psychedelics

  • 10:30–11:00 · Lecture · Module 2: Neurobiology & Brain States

    Cognitive Networks and the Neuroscience of Depression Under Psychedelics

    Sharmin Ghaznavi

    Examines cognitive network changes underlying depression and how psychedelics influence them.

    Depression · Psychedelics

  • 11:00–11:30 · Lecture · Module 2: Neurobiology & Brain States

    Plant Medicines and the Psychedelome

    Stephen Haggarty

    Discusses plant-derived medicines and the molecular landscape of psychedelic compounds.

    Psychedelics

  • 11:30–12:00 · Lecture · Module 2: Neurobiology & Brain States

    Advanced Meditation and the Third Wave of Meditation Research

    Matthew Sacchet

    Overview of advanced meditation and emerging directions in meditation research.

    Lifestyle & Integrative Psychiatry

  • 12:00–12:30 · Panel · Module 2: Neurobiology & Brain States

    Panel Discussion

    Jerrold F. Rosenbaum · Sharmin Ghaznavi · Stephen Haggarty · Matthew Sacchet

    Moderated discussion of the neurobiology and brain-state topics presented in Module 2.

    Psychedelics

Saturday, November 14

  • 09:35–10:05 · Lecture · Module 4: Clinical Expansion, Psychosomatics, and Translational Imaging

    MDMA-Assisted Therapy and Simultaneous Patient-Therapist Neuroimaging in Pain

    Vitaly Napadow

    Covers MDMA-assisted therapy for pain and neuroimaging of patient and therapist together.

    Psychedelics · Medical Comorbidity & C-L Psychiatry

Other topics at this meeting

Psychedelics 17Psychotherapy 4Drug Interactions & Safety 2Ketamine & Esketamine 2Medical Comorbidity & C-L Psychiatry 2Depression 1Diverse & Underserved Populations 1Lifestyle & Integrative Psychiatry 1Personality Disorders 1Drug Pipeline & Clinical Trials 1Practice, Policy & Workforce 1Treatment-Resistant Depression 1

Full program overview →